1-Benzyl 2-ethyl piperazine-1,2-dicarboxylate

Catalog No.: 
ACIUOX738
CAS No.: 
1822509-89-6
Molecular Formula: 
C15H20N2O4
Molecular Weight: 
292.33
1-Benzyl 2-ethyl piperazine-1,2-dicarboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$71.00In stockInquiry
250mg98%$120.00In stockInquiry
1g98%$321.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-Benzyl 2-ethyl piperazine-1,2-dicarboxylate
IUPAC Name1-benzyl 2-ethyl piperazine-1,2-dicarboxylate
MDL No.MFCD24849997
Molecular FormulaC15H20N2O4
Molecular Weight292.33
SMILESO=C(OCC)C1CNCCN1C(OCC2=CC=CC=C2)=O
InChI KeyJGAOTOPJSAYSPJ-UHFFFAOYSA-N
Synonym1-benzyl2-ethylpiperazine-1,2-dicarboxylate(WX191471);1-benzyl2-ethylpiperazine-1,2-dicarboxylate;1,2-Piperazinedicarboxylic acid, 2-ethyl 1-(phenylmethyl) ester
CAS No.1822509-89-6
PubChem CID135397196

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACIUOX738 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACMKJG320 route compound structure diagram
    ACMKJG320129798-91-0In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACIUOX738 route product structure diagram
    ACIUOX7381822509-89-6In Stock
Inquiry

2. ACIUOX738 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACIUOX738 route product structure diagram
    ACIUOX7381822509-89-6In Stock
Inquiry

3. ACIUOX738 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACIUOX738 route product structure diagram
    ACIUOX7381822509-89-6In Stock
Inquiry

Comments (0)